Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|June 20, 2014
Warfarin pharmacogenetics: to genotype or not to genotype, that is the questionL H Cavallari, E A Nutescu
Clinical Pharmacology and Therapeutics|September 16, 2011
Pharmacogenomics: application to the management of cardiovascular diseaseJ A Johnson, L H Cavallari, A L Beitelshees, et al.
Clinical Pharmacology and Therapeutics|December 30, 2016
Anticoagulation endpoints with clinical implementation of warfarin pharmacogenetic dosing in a real-world setting: A proposal for a new pharmacogenetic dosing approachM J Arwood, J Deng, K Drozda, et al.
Clinical Pharmacology and Therapeutics|March 2, 2012
Decreased warfarin clearance associated with the CYP2C9 R150H (*8) polymorphismY Liu, H Jeong, H Takahashi, et al.
Clinical Pharmacology and Therapeutics|January 29, 2011
The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African AmericansM A Perera, E Gamazon, L H Cavallari, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 17, 2008
Cytochrome P450 2C9 mediated metabolism in people with and without cancerS S Shord, L H Cavallari, M A G Viana, et al.
The Pharmacogenomics Journal|February 7, 2008
Beta-adrenergic receptor gene polymorphisms and hemodynamic response to dobutamine during dobutamine stress echocardiographyC L Aquilante, H N Yarandi, L H Cavallari, et al.
Journal of Thrombosis and Haemostasis : JTH|January 31, 2017
Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African AmericansW Hernandez, E R Gamazon, K Aquino-Michaels, et al.
Clinical Pharmacology and Therapeutics|January 15, 2010
Genetic and clinical predictors of warfarin dose requirements in African AmericansL H Cavallari, T Y Langaee, K M Momary, et al.
Clinical and Translational Science|January 12, 2016
Impact of GGCX, STX1B and FPGS Polymorphisms on Warfarin Dose Requirements in European-Americans and EgyptiansI S Hamadeh, M H Shahin, S M Lima, et al.
Pageof 2